EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis
Europe - FRA:ESF0 - FR0014000MR3 - Common Stock
62.32 EUR
-1.28 (-2.01%)
We assign a fundamental rating of 6 out of 10 to ESF0. ESF0 was compared to 19 industry peers in the Life Sciences Tools & Services industry. While ESF0 has a great profitability rating, there are some minor concerns on its financial health. ESF0 may be a bit undervalued, certainly considering the very reasonable score on growth These ratings would make ESF0 suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year ESF0 was profitable.
In the past year ESF0 had a positive cash flow from operations.
In the past 5 years ESF0 has always been profitable.
In the past 5 years ESF0 always reported a positive cash flow from operatings.
1.2 Ratios
ESF0 has a Return On Assets (3.54%) which is comparable to the rest of the industry.
ESF0 has a Return On Equity of 8.09%. This is in the better half of the industry: ESF0 outperforms 68.42% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.79%, ESF0 belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ESF0 is in line with the industry average of 7.19%.
The 3 year average ROIC (8.70%) for ESF0 is below the current ROIC(9.79%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROIC | 9.79% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
With a Profit Margin value of 5.44%, ESF0 perfoms like the industry average, outperforming 47.37% of the companies in the same industry.
In the last couple of years the Profit Margin of ESF0 has grown nicely.
ESF0 has a better Operating Margin (15.59%) than 63.16% of its industry peers.
In the last couple of years the Operating Margin of ESF0 has grown nicely.
ESF0's Gross Margin of 23.29% is on the low side compared to the rest of the industry. ESF0 is outperformed by 73.68% of its industry peers.
ESF0's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESF0 is creating some value.
ESF0 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ESF0 has more shares outstanding
ESF0 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.70 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
ESF0 has a Altman-Z score of 2.70. This is comparable to the rest of the industry: ESF0 outperforms 52.63% of its industry peers.
ESF0 has a debt to FCF ratio of 5.25. This is a neutral value as ESF0 would need 5.25 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 5.25, ESF0 is doing good in the industry, outperforming 68.42% of the companies in the same industry.
ESF0 has a Debt/Equity ratio of 0.77. This is a neutral value indicating ESF0 is somewhat dependend on debt financing.
ESF0's Debt to Equity ratio of 0.77 is on the low side compared to the rest of the industry. ESF0 is outperformed by 63.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Altman-Z | 2.7 |
ROIC/WACC1.27
WACC7.71%
2.3 Liquidity
ESF0 has a Current Ratio of 1.26. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0's Current ratio of 1.26 is on the low side compared to the rest of the industry. ESF0 is outperformed by 73.68% of its industry peers.
ESF0 has a Quick Ratio of 1.19. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0's Quick ratio of 1.19 is fine compared to the rest of the industry. ESF0 outperforms 63.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
ESF0 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.50%, which is quite good.
Measured over the past years, ESF0 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.34% on average per year.
ESF0 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.53%.
ESF0 shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.78% yearly.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
3.2 Future
The Earnings Per Share is expected to grow by 12.69% on average over the next years. This is quite good.
ESF0 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.22% yearly.
EPS Next Y13.37%
EPS Next 2Y13.55%
EPS Next 3Y13.96%
EPS Next 5Y12.69%
Revenue Next Year5.71%
Revenue Next 2Y5.98%
Revenue Next 3Y6.27%
Revenue Next 5Y6.22%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
ESF0 is valuated rather expensively with a Price/Earnings ratio of 17.31.
ESF0's Price/Earnings ratio is rather cheap when compared to the industry. ESF0 is cheaper than 89.47% of the companies in the same industry.
ESF0 is valuated rather cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 15.65, which indicates a correct valuation of ESF0.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ESF0 indicates a rather cheap valuation: ESF0 is cheaper than 89.47% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.86. ESF0 is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.31 | ||
| Fwd PE | 15.65 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaply inside the industry as 89.47% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ESF0 is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.48 | ||
| EV/EBITDA | 8.66 |
4.3 Compensation for Growth
ESF0's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ESF0 has a very decent profitability rating, which may justify a higher PE ratio.
ESF0's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.29
PEG (5Y)0.94
EPS Next 2Y13.55%
EPS Next 3Y13.96%
5. Dividend
5.1 Amount
ESF0 has a yearly dividend return of 0.94%, which is pretty low.
ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.71. ESF0 pays more dividend than 84.21% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, ESF0's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
5.2 History
The dividend of ESF0 is nicely growing with an annual growth rate of 16.51%!
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
ESF0 pays out 54.91% of its income as dividend. This is a bit on the high side, but may be sustainable.
ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP54.91%
EPS Next 2Y13.55%
EPS Next 3Y13.96%
FRA:ESF0 (9/18/2025, 7:00:00 PM)
62.32
-1.28 (-2.01%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners34.16%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.35B
Analysts70
Price Target64.88 (4.11%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.12%
PT rev (3m)7.87%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.66%
EPS NY rev (3m)-1.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.27%
Revenue NY rev (3m)-0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.31 | ||
| Fwd PE | 15.65 | ||
| P/S | 1.65 | ||
| P/FCF | 14.48 | ||
| P/OCF | 8.63 | ||
| P/B | 2.45 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.66 |
EPS(TTM)3.6
EY5.78%
EPS(NY)3.98
Fwd EY6.39%
FCF(TTM)4.3
FCFY6.91%
OCF(TTM)7.22
OCFY11.58%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.29
PEG (5Y)0.94
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROCE | 12.64% | ||
| ROIC | 9.79% | ||
| ROICexc | 10.74% | ||
| ROICexgc | 34.1% | ||
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% | ||
| FCFM | 11.37% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexcg growth 3Y-18.17%
ROICexcg growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Debt/EBITDA | 2.1 | ||
| Cap/Depr | 84.94% | ||
| Cap/Sales | 7.7% | ||
| Interest Coverage | 9.93 | ||
| Cash Conversion | 77.37% | ||
| Profit Quality | 209.21% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.7 |
F-Score7
WACC7.71%
ROIC/WACC1.27
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y13.37%
EPS Next 2Y13.55%
EPS Next 3Y13.96%
EPS Next 5Y12.69%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.71%
Revenue Next 2Y5.98%
Revenue Next 3Y6.27%
Revenue Next 5Y6.22%
EBIT growth 1Y14.03%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year87.7%
EBIT Next 3Y30.85%
EBIT Next 5Y22.29%
FCF growth 1Y113.13%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.31%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%